OTTAWA, Ontario, Sept. 20, 2017 /Weed Wire/ — Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (TSX VENTURE:TBP)(OTCQB:TBPMF), today announced that it has signed a letter of intent (LOI) with a major player of the healthcare specialty industry.
Tag Archives: Healthcare
TORONTO, Ontario, May 16, 2017 /Weed Wire/ — Alternate Health Corp. (CSE:AHG, OTC:AHGIF), a diverse healthcare company revolutionizing patient care and research in the emerging medical cannabis industry, announced today the completion of its initial study to demonstrate the effectiveness of cannabinoids in treating chronic post-Zika virus symptoms.
With its Humboldt Institute for Interdisciplinary Marijuana Research, Humboldt State University in California has been at the academic forefront of marijuana since 2012, but other institutions of higher education in the state are starting to follow suit.
PORTLAND, Maine, Dec. 1, 2016 /Weed Wire/ — Wellness Connection of Maine (WCM) and Becky DeKeuster, WCM’s Co-Founder, announced today that Ms. DeKeuster has left the company to pursue new professional opportunities.
LONDON, Sept. 7, 2016 /Weed Wire/ — GW Pharmaceuticals plc (Nasdaq:GWPH) (AIM:GWP) (“GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, today announced that Justin Gover, GW’s Chief Executive Officer, is scheduled to present at the Morgan Stanley Global Healthcare Conference.
LONDON, May 31, 2016 /Weed Wire/ — GW Pharmaceuticals plc (Nasdaq:GWPH) (AIM:GWP) today announced that Justin Gover, GW’s Chief Executive Officer, is scheduled to present at the Goldman Sachs 37th Annual Global Healthcare Conference.
DENVER, Jan. 8, 2015 /Weed Wire/ — The second free IMPACT event on Seniors and Cannabis will be held on Saturday, January 9th, from noon to 5 pm at Green Labs in Denver’s RiNo district.
SAN FRANCISCO, Aug. 7, 2015 /PRNewswire/ — HelloMD (www.hellomd.com) today announces surprising user demographic of those that use their service.
CHICAGO, March 19, 2015 /Weed Wire/ – MedMJ, a conference to cover all aspects for investors of medical marijuana, from emerging state medical marijuana laws, healthcare liabilities and groundbreaking patient research and development, has merged with the Marijuana Investor Summit, a conference that provides entrepreneurs and investors with a comprehensive understanding of this industry and how to invest in it from seed to sale.
One of those levels of resistance that continues even after legalization is the idea that publishing, writing, or reading about the newly-legal substance is disreputable, and the temptation to demand silence.
Although the marijuana industry has made considerable gains in the last several years, marijuana advertising remains more or less an untapped market.
It has been 15 years since the advent of medical marijuana in the United States. A new study published by JAMA Internal Medicine sought to determine the effect the availability of legal medical marijuana has on the rate of opioid overdoses in states where patients have access to medical marijuana.
Today there are 23 states that allow the medical use of cannabis. Colorado and Washington also allow recreational use. It is imperative for physicians and the healthcare industry to expand their knowledge of a plant some of their patients are ingesting on a regular basis.